Optimal revascularization strategies for ST-Segment elevation myocardial infarction in the elderly patient

American Journal of Geriatric Cardiology

Volumn 16, Issue 5, 2007, Pages 295-303

  Klein, Lloyd W ^a  

^a RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ALGORITHM; ELECTROCARDIOGRAPHY; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MIDDLE AGED; MORTALITY; PATIENT SELECTION; REVIEW; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALGORITHMS; ELECTROCARDIOGRAPHY; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT SELECTION; RISK ASSESSMENT; SURVIVAL RATE; THROMBOLYTIC THERAPY;

EID: 38449087308     PISSN: 10767460     EISSN: 1751715X     Source Type: Journal    
DOI: 10.1111/j.1076-7460.2007.07328.x     Document Type: Review

References (62)

1. Goldberg RJ, McCormick D, Gurwitz JH, et al. Age-related trends in short- and long-term survival after acute myocardial infarction: a 20 year population based perspective (1975-1995). Am J Cardiol. 1998;82:1311-1317.
2. Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA. 1992;268:1417-1422.
3. Lee PY, Alexander KP, Hammill BG, et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA. 2001;286(6):708-713.
4. Van de Werf F, Topol EJ, Lee KL, et al, for the GUSTO Investigators. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. JAMA. 1995;273:1586-1591.
5. White HD, Barbash GI, Califf RM, et al, for the GUSTO-1 Investigators. Age and outcome with contemporary thrombolytic therapy: results from the GUSTO-1 Trial. Circulation. 1996;94:1826-1833.
6. Gregoratos G. Clinical manifestations of acute myocardial infarction in older patients. Am J Geriatr Cardiol. 2001;10(6):345-347.
7. Klein L.W. Percutaneous coronary intervention in the elderly patient. J Invasive Cardiol. 2006;18:286-295.
8. Alexander KP, Newby LK, Armstrong PW, et al. Acute coronary care in the elderly, part I.I. ST segment elevation myocardial infarction. Circulation. 2007;115:2570-2589.
9. Lee KL, Woodlief LH, Topol EJ, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Circulation. 1995;91:1659-1668.
10. Halon DA, Adawi S, Dobrecky-Mery I, et al. Importance of increasing age on the presentation and outcome of acute coronary syndromes in elderly patients. J Am Coll Cardiol. 2004;43:346-352.
11. Aronow W.S. Silent M.I. Prevalence and prognosis in older patients diagnosed by routine elctrocardiograms. Geriatrics. 2003;58:24-26, 36-40.
12. Mehta RH, Rathore SS, Radford MJ, et al. Acute myocardial infarction in the elderly: differences by age. J Am Coll Cardiol. 2001;38:736-740.
13. Sheifer S, Rathore S, Gersh B, et al. Time to presentation with acute myocardial infarction in the elderly: associations with race, sex, and socioeconomic characteristics. Circulation. 2000;102(14):1651-1656.
14. Berger AK, Radford MJ, Krumholz H.M. Factors associated with delay in reperfusion therapy in elderly patients with acute myocardial infarction: analysis of the cooperative cardiovascular project. Am Heart J. 2000;139(6):985-992.
15. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet. 1994;343:311-322.
16. De Boer MJ, Ottervanger JP, van't Hof AW, et al. Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol. 2002;39:1723-1728.
17. Berger AK, Radford MJ, Wang Y, et al. Thrombolytic therapy in older patients. J Am Coll Cardiol. 2000;36(2):366-374.
18. Thiemann DR, Coresh J, Schulman SP, et al. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation. 2002;101:2239-2246.
19. Soumerai SB, McLaughlin TJ, Ross-Degnan D, et al. Effectiveness of thrombolytic therapy for acute myocardial infarction in the elderly: cause for concern in the old-old. Arch Intern Med. 2002;162(5):561-568.
20. Mehta RH, Granger CB, Alexander KP, et al. Reperfusion strategies for acute myocardial infarction in the elderly: benefits and risks. J Am Coll Cardiol. 2005;45(4):471-478.
21. Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Lancet. 1987;2:871-874.
22. Randomised trial if intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988;2:349-360.
23. The Gusto V Investigation. Reperfusion therapy for acute myocardial information with fibrinolutic toe therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition. Lancet. 2001;357:1905-1914.
24. Gersh BJ, Stone GW, White HD, et al. Pharmacological facilitation of primary percutaneous intervention for acute myocardial infarction. JAMA. 2005;293:979-986.
25. Borden WB, Faxon D.P. Facilitated percutaneous coronary intervention. J Am Coll Cardiol. 2006;48:1120-1128.
26. Thiemann D.R. Primary angioplasty for elderly patients with myocardial infarction: theory, practice and possibilities. J Am Coll Cardiol. 2002;39:1729-1732.
27. Gusto IIb Angioplasty Substudy Investigations. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activation for acute myocardial infarction. N Engl J Med. 1997;336:1621-1628.
28. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA. 1997;278:2093-2098.
29. Berger AK, Schulman KA, Gersh BJ, et al. Primary coronary angioplasty vs. thrombolysis for the management of acute myocardial infarction in elderly patients. JAMA. 1999;282:341-348.
30. Zijlstra F, de Boer MJ, Hoorntje JC, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328:680-684.
31. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1993;328:673-679.
32. O'Neill WW, de Boer MJ, Gibbons RJ, et al. Lessons from the pooled outcome of PAMI, Zwolle, and Mayo Clinic Randomized Trials of primary angioplasty versus thrombolytic therapy of acute myocardial infarction. J Invasive Cardiol. 1998;10:4A-10A.
33. Grines C. SENIOR PAMI. A prospective randomized trial of primary angioplasty and thrombolytic therapy in elderly patients with acute myocardial infarction. TCT 2005; October 16-21, 2005; Washington, DC.
34. Zahn R, Schiele R, Schneider S, et al. Primary angioplasty verses intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Infarction Registry. J Am Coll Cardiol. 2001;37(7):1827-1835.
35. Klein L.W. Optimal therapy for cardiogenic shock: the emerging role of coronary angioplasty. J Am Coll Cardiol. 1992;19:654-656.
36. Klein LW, Anderson HV, Brindis R, et al, on behalf of the ACC-NCDR. Predictors of outcome of primary PCI in ST segment elevation myocardial infarction in 6521 consecutive cases during 2001: a report from the American College of Cardiology-National Cardiovascular Data Registry. Circulation. 2002;106:II-363.
37. Shaw R, Anderson H, Brindis R, et al. Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000. J Am Coll Cardiol. 2002;39(7):1104-1112.
38. Klein LW, Block P, Brindis RG, et al. Weintraub WS on behalf of the ACC-NCDR Registry. Percutaneous coronary interventions in octogenarians in the American College of Cardiology - National Cardiovascular Data Registry: Development of a nomogram predictive of in-hospital mortality. Increased risk associated with acute myocardial infarction. J Am Coll Cardiol. 2002;40:394-402.
39. Rao SV, O'Grady K, Pieper KS, et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol. 2005;96:1200-1206.
40. Abbas AE, Brodie B, Dixon S, et al. Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2005;96:173-176.
41. Eikelboom JW, Mehta SR, Anand SS, et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation. 2006;114:774-782.
42. Alexander KP, Chen AY, Roe MT, et al. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA. 2005;294:3108-3116.
43. ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100 000 patients in randomized trials. Circulation. 1998;97:2202-2212.
44. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet. 1986;2:57-66.
45. Ferrari AU, Radaelli A, Centala M. Aging and the cardiovascular system. J Appl Physiol. 2003;95:2591-2597.
46. Guagliumi G, Stone GW, Cox DA, et al. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation. 2004;110(12):1598-1604.
47. Halkin A, Stone GW, Grines CG, et al. Outcomes of patients consented but not randomized in a trial of primary percutaneous intervention in acute myocardial infarction (the CADILLAC Registry). Am J Cardiol. 2005;96:1649-1652.
48. Turco MA, Cox DA, Garcia E, et al. Baseline features and clinical results in patients excluded from large interventional trials of reperfusion strategies in acute myocardial infarction. The Cadillac Registry. J Am Coll Cardiol. 2003;41:368A.
49. Montalescot G, Barragan P, Wittenberg D, et al, for the Admiral Investigation. Platelet glycoprotein IIb/ IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med. 2001;344:1895-1903.
50. Antoniucci D, Rodriguez A, Hempel A, et al. A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction. J Am Coll Cardiol. 2003;42:1879-1885.
51. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/ SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006;113:156-175.
52. Klein LW, Shaw RE, Krone RJ, et al. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model. Am J Cardiol. 2005;96:35-41.
53. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999;341:625-634.
54. Dzavik V, Sleeper LA, Picard MH, et al. Outcomes of the patients aged> or =75 years in the Should we emergently revascularize Occluded coronaries in cardiogenic shock (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization? Am Heart J. 2005;149:1128-1134.
55. Smith SC, Dove JT, Jacobs AK, et al. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)?executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol. 2001;37(8)2215-2239.
56. Antman EM, Anbe DT, Armstrong PW, et al. ACC/ AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004;44:671-719.
57. Menon V, Hochman J.S. Management of cardiogenic shock complicating acute myocardial infarction. Heart. 2002;88:531-537.
58. Dauerman HL, Goldberg RJ, Malinski M, et al. Outcomes and early revascularization for patients =65 years of age with cardiogenic shock. Am J Cardiol. 2001;87:844-848.
59. Dauerman HL, Ryan TJ Jr, Piper WD, et al. Outcomes of percutaneous coronary intervention among elderly patients in cardiogenic shock: a multicenter, decade-long experience. J Invasive Cardiol. 2003;15:380-384.
60. Antoniucci D, Valenti R, Santoro GM, et al. Systematic primary angioplasty in octogenarian and older patients. Am Heart J. 1999;138(4, pt 1):670-674.
61. Berger AK, Radford MJ, Krumholz H.M. Cardiogenic shock complicating acute myocardial infarction in elderly patients: does admission to a tertiary center improve survival? Am Heart J. 2002;143:768-776.
62. Prasad A, Lennon RJ, Rihal CS, et al. Outcomes of elderly patients with cardiogenic shock treated with early percutaneous revascularization. Am Heart J. 2004;147:1066-1070.